Brad Kahl: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Wang, Michael L., Rule, Simon, Martin, Peter, Goy, Andre, Auer, Rebecca, Kahl, Brad S., Jurczak, Wojciech, Advani, Ranjana H., Romaguera, Jorge E., Williams, Michael E., Barrientos, Jacqueline C., Chm

Journal:

Boston Medical and Surgical Journal

Year:

2013

Language:

english

File:

PDF, 624 KB

english, 2013

2

Bendamustine Produces Durable Responses With an Acceptable Safety Profile in Patients With Rituximab-Refractory Indolent Non-Hodgkin Lymphoma

Bruce D. Cheson, Jonathan W. Friedberg, Brad S. Kahl, Richard H. Van der Jagt, Lothar Tremmel

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2010

Language:

english

File:

PDF, 130 KB

english, 2010

3

Comparison of organ residence time estimation methods for radioimmunotherapy dosimetry and treatment planning—patient studies

He, Bin, Wahl, Richard L., Sgouros, George, Du, Yong, Jacene, Heather, Kasecamp, Wayne R., Flinn, Ian, Hammes, Richard J., Bianco, Jay, Kahl, Brad, Frey, Eric C.

Journal:

Medical Physics

Year:

2009

Language:

english

File:

PDF, 135 KB

english, 2009

4

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

Roberts, Andrew W., Davids, Matthew S., Pagel, John M., Kahl, Brad S., Puvvada, Soham D., Gerecitano, John F., Kipps, Thomas J., Anderson, Mary Ann, Brown, Jennifer R., Gressick, Lori, Wong, Shekman,

Journal:

New England Journal of Medicine

Year:

2015

Language:

english

File:

PDF, 238 KB

english, 2015

5

Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era

King, Rebecca L., Nowakowski, Grzegorz S., Witzig, Thomas E., Scott, David W., Little, Richard F., Hong, Fangxin, Gascoyne, Randy D., Kahl, Brad S., Macon, William R

Journal:

Blood Cancer Journal

Year:

2018

Language:

english

File:

PDF, 680 KB

english, 2018

6

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma

Ivana N. M. Micallef, Brad S. Kahl, Matthew J. Maurer, Ahmet Dogan, Stephen M. Ansell, Joseph P. Colgan, Susan Geyer, David J. Inwards, William L. White, Thomas M. Habermann

Journal:

Year:

2006

Language:

english

File:

PDF, 122 KB

english, 2006

7

Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma : Results from a Multicenter Study

Brad S. Kahl, Nancy L. Bartlett, John P. Leonard, Ling Chen, Kristen Ganjoo, Michael E. Williams, Myron S. Czuczman, K. Sue Robinson, Robin Joyce, Richard H. van der Jagt, Bruce D. Cheson

Journal:

Year:

2010

Language:

english

File:

PDF, 186 KB

english, 2010

8

Follicular lymphoma: Management options in the era of targeted therapy

Christopher G. Peterson, Brad S. Kahl

Journal:

Current Treatment Options in Oncology

Year:

2005

Language:

english

File:

PDF, 516 KB

english, 2005

9

Frontline therapy in mantle cell lymphoma: The role of high-dose therapy and integration of new agents

Journal:

Current Hematologic Malignancy Reports

Year:

2009

Language:

english

File:

PDF, 221 KB

english, 2009

10

Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis

Mahmoud Abouraya, James C. Sacco, Brad S. Kahl, Lauren A. Trepanier

Journal:

British Journal of Clinical Pharmacology

Year:

2011

Language:

english

File:

PDF, 976 KB

english, 2011

11

Bendamustine for treatment of chronic lymphocytic leukemia

Chang, Julie Elizabeth, Kahl, Brad Steven

Journal:

Expert Opinion on Pharmacotherapy

Year:

2012

Language:

english

File:

PDF, 276 KB

english, 2012

12

Mantle cell lymphoma: The promise of new treatment options

Andre Goy, Brad Kahl

Journal:

Critical Reviews in Oncology/Hematology

Year:

2011

Language:

english

File:

PDF, 309 KB

english, 2011

13

Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond First Complete Response or First Partial Response

Marcie R. Tomblyn, Marian Ewell, Christopher Bredeson, Brad S. Kahl, Stacey A. Goodman, Mary M. Horowitz, Julie M. Vose, Robert S. Negrin, Ginna G. Laport

Journal:

Biology of Blood and Marrow Transplantation

Year:

2011

Language:

english

File:

PDF, 241 KB

english, 2011

14

Chemotherapy Combinations With Monoclonal Antibodies in Non-Hodgkin’s Lymphoma

Journal:

Seminars in Hematology

Year:

2008

Language:

english

File:

PDF, 102 KB

english, 2008

15

The Future of B-Cell Lymphoma Therapy: The B-Cell Receptor and its Downstream Pathways

Vaishalee P. Kenkre, Brad S. Kahl

Journal:

Current Hematologic Malignancy Reports

Year:

2012

Language:

english

File:

PDF, 156 KB

english, 2012

16

5.43 Patterns of Nodal Response and Lymphocytosis in Patients with Previously Treated CLL Receiving the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kδ) Inhibitor, CAL-101 (GS-1101) Alone or in Combination with Rituximab (R) or Bendamustine (B)

Jennifer R. Brown, Thomas M. Jahn, Richard R. Furman, John P. Leonard, Stephen E. Spurgeon, John C. Byrd, Don M. Benson, Steven E. Coutre, Nina D. Wagner-Johnston, Ian W. Flinn, Brad S. Kahl, Marshall

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 112 KB

english, 2011

17

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma

David T Yang, Ken H Young, Brad S Kahl, Stephanie Markovina, Shigeki Miyamoto

Journal:

Molecular Cancer

Year:

2008

Language:

english

File:

PDF, 602 KB

english, 2008

18

Current Status of Targeted Therapies for Mantle Cell Lymphoma

Dr Julie E. Chang MD, Brad S. Kahl

Journal:

Year:

2011

Language:

english

File:

PDF, 221 KB

english, 2011

19

Early Results of a Phase I Trial of Oblimersen Sodium for Relapsed or Refractory Waldenström's Macroglobulinemia

Gertz, Morie A., Geyer, Susan M., Badros, Ashraf, Kahl, Brad S., Erlichman, Charles

Journal:

Clinical Lymphoma

Year:

2005

Language:

english

File:

PDF, 95 KB

english, 2005

20

Eastern Cooperative Oncology Group 4402: Rituximab Extended Schedule or Retreatment Trial (RESORT)

Journal:

Clinical Lymphoma & Myeloma

Year:

2006

Language:

english

File:

PDF, 860 KB

english, 2006

21

Dose-Intense and Dose-Dense Regimens in Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphoma

Journal:

Clinical Lymphoma & Myeloma

Year:

2007

Language:

english

File:

PDF, 44 KB

english, 2007

22

Thalidomide Maintenance Following High-Dose Melphalan with Autologous Stem Cell Support in Myeloma

Chang, Julie E., Juckett, Mark B., Callander, Natalie S., Kahl, Brad S., Gangnon, Ronald E., Mitchell, Teri L., Longo, Walter L.

Journal:

Clinical Lymphoma & Myeloma

Year:

2008

Language:

english

File:

PDF, 129 KB

english, 2008

23

Meeting Highlights from: The 50th Annual Meeting of the American Society of Hematology; San Francisco, CA; December 6–9, 2008

Cunningham, Sonia, Muneer, Sabeeha, Jagannath, Sundar, Kahl, Brad

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 168 KB

english, 2009

24

Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens

Kelly, Jennifer L., Toothaker, Stephen R., Ciminello, Lauren, Hoelzer, Dieter, Holte, Harald, LaCasce, Ann S., Mead, Graham, Thomas, Deborah, Van Imhoff, Gustaaf W., Kahl, Brad S., Cheson, Bruce D., M

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 104 KB

english, 2009

25

Rituximab and CHOP Chemotherapy Plus GM-CSF for Previously Untreated Diffuse Large B-Cell Lymphoma in the Elderly: A Wisconsin Oncology Network Study

Julie E. Chang, Songwong Seo, Kyungmann M. Kim, Jae E. Werndli, Wayne A. Bottner, Gilberto A. Rodrigues, Federico A. Sanchez, Thomas J. Saphner, Walter L. Longo, Brad S. Kahl

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2010

Language:

english

File:

PDF, 128 KB

english, 2010

26

Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop

Williams, Michael E., Bernstein, Steven H., Jares, Pedro, Kahl, Brad S., Witzig, Thomas E., Gordon, Leo I.

Journal:

Leukemia and Lymphoma

Year:

2013

Language:

english

File:

PDF, 231 KB

english, 2013

27

Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

Stiff, Patrick J., Unger, Joseph M., Cook, James R., Constine, Louis S., Couban, Stephen, Stewart, Douglas A., Shea, Thomas C., Porcu, Pierluigi, Winter, Jane N., Kahl, Brad S., Miller, Thomas P., Tub

Journal:

New England Journal of Medicine

Year:

2013

Language:

english

File:

PDF, 781 KB

english, 2013

28

PI3-Kinase Inhibitors in Chronic Lymphocytic Leukemia

Chang, Julie E., Kahl, Brad S.

Journal:

Current Hematologic Malignancy Reports

Year:

2014

Language:

english

File:

PDF, 451 KB

english, 2014

29

PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

Gopal, Ajay K., Kahl, Brad S., de Vos, Sven, Wagner-Johnston, Nina D., Schuster, Stephen J., Jurczak, Wojciech J., Flinn, Ian W., Flowers, Christopher R., Martin, Peter, Viardot, Andreas, Blum, Kristi

Journal:

New England Journal of Medicine

Year:

2014

Language:

english

File:

PDF, 674 KB

english, 2014

30

Inhibitor kinazy Brutona u chorych z nawrotowym lub opornym na leczenie chłoniakiem z komórek płaszcza – wyniki międzynarodowego, wieloośrodkowego, badania II fazy z ibrutynibem (PCI-32765) – EHA Encore

Jurczak, Wojciech, Rule, Simon, Martin, Peter, Auer, Rebecca, Kahl, Brad S., Giza, Agnieszka, Jachimczak, Bożena, Advani, Ranjana H., Romaguera, Jorge, Williams, Michael, Barrientos, Jacqueline, Chmie

Journal:

Acta Haematologica Polonica

Year:

2013

File:

PDF, 1.09 MB

2013

31

Augmented and standard Berlin–Frankfurt–Münster chemotherapy for treatment of adult acute lymphoblastic leukemia

Chang, Julie E., Medlin, Stephen C., Kahl, Brad S., Longo, Walter L., Williams, Eliot C., Lionberger, Jack, Kim, Kyungmann, Kim, Jihoon, Esterberg, Elizabeth, Juckett, Mark B.

Journal:

Leukemia and Lymphoma

Year:

2008

Language:

english

File:

PDF, 431 KB

english, 2008

32

Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop

Gordon, Leo I., Bernstein, Steven H., Jares, Pedro, Kahl, Brad S., Witzig, Thomas E., Dreyling, Martin

Journal:

Leukemia and Lymphoma

Year:

2014

Language:

english

File:

PDF, 159 KB

english, 2014

33

A phase I study of PRO131921, a novel anti-CD20 monoclonal antibody in patients with relapsed/refractory CD20+ indolent NHL: Correlation between clinical responses and AUC pharmacokinetics

Casulo, Carla, Vose, Julie M., Ho, William Y., Kahl, Brad, Brunvand, Mark, Goy, Andre, Kasamon, Yvette, Cheson, Bruce, Friedberg, Jonathan W.

Journal:

Clinical Immunology

Year:

2014

Language:

english

File:

PDF, 767 KB

english, 2014

34

Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop

Williams, Michael E., Connors, Joseph M., Dreyling, Martin H., Gascoyne, Randy D., Kahl, Brad S., Leonard, John P., Press, Oliver W., Wilson, Wyndham H.

Journal:

Leukemia and Lymphoma

Year:

2011

Language:

english

File:

PDF, 230 KB

english, 2011

35

Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era

Fletcher, Christopher D., Kahl, Brad S.

Journal:

Leukemia and Lymphoma

Year:

2014

Language:

english

File:

PDF, 1.29 MB

english, 2014

36

Bendamustine: more ammunition in the battle against mantle cell lymphoma

Chang, Julie E., Kahl, Brad S.

Journal:

Leukemia and Lymphoma

Year:

2012

Language:

english

File:

PDF, 141 KB

english, 2012

37

Phase II Study of Weekly Low-Dose Paclitaxel for Relapsed and Refractory Non-Hodgkin's Lymphoma: A Wisconsin Oncology Network Study

Kahl, Brad S., Bailey, Howard H., Kim, Kyung-Mann, Smith, Eileen P., Turman, Nancy, Smith, Jamie, Werndli, Jae, McGovern, James, Jumonville, Alcee, Williams, Eliot C., Longo, Walter L.

Journal:

Cancer Investigation

Year:

2005

Language:

english

File:

PDF, 115 KB

english, 2005

38

Excessive toxicity of the high dose thiotepa and etoposide regimen when combined with radiation: Long-term autologous transplantation experience in follicular and mantle cell lymphoma

Fenske, Timothy S., Kahl, Brad S., Eickhoff, Jens, Mitchell, Teri L., Smith, Eileen P., Atkinson, Elizabeth, Mccoy, Alice Garry, Eckstein, Linda, Flynn, Bridget, Mcmannes, Jan, Howard, Steven, Longo,

Journal:

Leukemia and Lymphoma

Year:

2005

Language:

english

File:

PDF, 181 KB

english, 2005

39

Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial

Advani, Ranjana H., Hong, Fangxin, Horning, Sandra J., Kahl, Brad S., Manola, Judith, Swinnen, Lode J., Habermann, Thomas M., Ganjoo, Kristen

Journal:

Leukemia and Lymphoma

Year:

2012

Language:

english

File:

PDF, 155 KB

english, 2012

40

A 5-Drug Regimen Maximizing the Dose of Cyclophosphamide is Effective Therapy for Adult Burkitt or Burkitt-like Lymphomas

Kujawski, Lisa A., Longo, Walter L., Williams, Eliot C., Turman, Nancy J., Brandt, Nancy, Mosher, Deane F., Eickhoff, Jens C., Kahl, Brad S.

Journal:

Cancer Investigation

Year:

2007

Language:

english

File:

PDF, 150 KB

english, 2007

41

Immunohistochemical evaluation of MYC expression in mantle cell lymphoma

Oberley, Matthew J, Rajguru, Saurabh A, Zhang, Chong, Kim, KyungMann, Shaw, Gene R, Grindle, Kreg M, Kahl, Brad S, Kanugh, Craig, Laffin, Jennifer, Yang, David T

Journal:

Year:

2013

Language:

english

File:

PDF, 685 KB

english, 2013

42

Follicular lymphoma: emerging therapeutic strategies

Kenkre, Vaishalee P, Kahl, Brad S

Journal:

Expert Review of Hematology

Year:

2010

Language:

english

File:

PDF, 592 KB

english, 2010

43

Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)

Ganjoo, Kristen, Hong, Fangxin, Horning, Sandra J., Gascoyne, Randy D., Natkunam, Yasodha, Swinnen, Lode J., Habermann, Thomas M., Kahl, Brad S., Advani, Ranjana H.

Journal:

Leukemia and Lymphoma

Year:

2014

Language:

english

File:

PDF, 325 KB

english, 2014

44

Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)

Swinnen, Lode J., Li, Hailun, Quon, Andrew, Gascoyne, Randy, Hong, Fangxin, Ranheim, Erik A., Habermann, Thomas M., Kahl, Brad S., Horning, Sandra J., Advani, Ranjana H.

Journal:

British Journal of Haematology

Year:

2015

Language:

english

File:

PDF, 495 KB

english, 2015

45

What Is the Best Initial Therapy for a Patient With Symptomatic Low-Grade Follicular Lymphoma?

Kenkre, Vaishalee P., Kahl, Brad S.

Journal:

The Cancer Journal

Year:

2012

Language:

english

File:

PDF, 516 KB

english, 2012

46

Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20 + lymphoid malignancies

Roberts, Andrew W., Advani, Ranjana H., Kahl, Brad S., Persky, Daniel, Sweetenham, John W., Carney, Dennis A., Yang, Jianning, Busman, Todd B., Enschede, Sari H., Humerickhouse, Roderick A., Seymour,

Journal:

British Journal of Haematology

Year:

2015

Language:

english

File:

PDF, 211 KB

english, 2015

47

Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation

Nazeef, Moniba, Kahl, Brad S.

Journal:

Current Treatment Options in Oncology

Year:

2015

Language:

english

File:

PDF, 911 KB

english, 2015

48

A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma

Goy, André, Hernandez-Ilzaliturri, Francisco J., Kahl, Brad, Ford, Peggy, Protomastro, Ewelina, Berger, Mark

Journal:

Leukemia and Lymphoma

Year:

2014

Language:

english

File:

PDF, 178 KB

english, 2014

49

Treatment of Synchronous Mantle Cell Lymphoma and Small Lymphocytic Lymphoma with Bendamustine and Rituximab

Kourelis, Taxiarchis V., Kahl, Brad S., Benn, Peter, Delach, Judith A., Bilgrami, Syed F.

Journal:

Acta Haematologica

Year:

2011

Language:

english

File:

PDF, 261 KB

english, 2011

50

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

de Vos, Sven, Forero-Torres, Andres, Ansell, Stephen M, Kahl, Brad, Cheson, Bruce D, Bartlett, Nancy L, Furman, Richard R, Winter, Jane N, Kaplan, Henry, Timmerman, John, Whiting, Nancy C, Drachman, J

Journal:

Journal of Hematology & Oncology

Year:

2014

Language:

english

File:

PDF, 660 KB

english, 2014

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски